New test detects cancer risk in type 2 diabetes patients
Levels of proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and high sensitivity C-reactive protein (hsCRP) were measured at the start of the study.
Levels of proinflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and high sensitivity C-reactive protein (hsCRP) were measured at the start of the study.